Departures Capital, a major public markets media platform with an international audience, and The Conscious Fund, the most active early-stage investor in the psychedelic medicine sector, are delighted to announce a partnership to support the rapidly increasing number of psychedelic medicine companies trading on public markets.
The partnership will help public companies with messaging and outreach to retail investors, drawing on Departure’s Capital’s large user base and The Conscious Fund’s expertise within the sector. Given the fast-moving market, complex science, and rapid development, the ability of psychedelic medicine companies to engage with an investor audience is essential.
With companies like Cybin heading for the NYSE, increasing listings for smaller entities on the CSE, and the NASDAQ drawing the larger players, the public markets are becoming competitive places where investor relations are critical.
Aaron Misere, CEO at Departures Capital, commented: “We are very pleased to be partnering with the conscious fund at this crucial time during this psychedelic renaissance. The team and I at Departures Capital are excited to connect investors with innovative and revolutionary companies paving the way forward in the psychedelics space. We look forward to working with The Conscious Fund’s diverse portfolio of new and exciting players in the sector.”
Henri Sant-Cassia, Partner at The Conscious Fund, added: “Aaron has built a very large audience of investors in innovative categories, and for the psychedelic medicine industry, this is a key audience. We are delighted to be working with Departures Capital to exposure the leading companies in the space to a wider group of backers.”
About Departures Capital
Departures Capital is an entertainment network focused on informing investors about the latest investment news. Initially started in Canada, Departures Capital has grown to a truly international scale with audiences in all parts of the world.
Its main host, Aaron Missere, has been a critical part of Departures Capital’s success. A successful real estate and stock investor, his passion to educate and inform is well known amongst his audience and peers. Departures Capital is a result of his goal to bring important investment news to his family, friends and audience and to help them make smarter and more informed investment decisions.
Contact:
Aaron Missere
Founder and CEO
Email: info@departurescapital.com
Website: www.departurescapital.com
About The Conscious Fund
The Conscious Fund is the most active early-stage venture fund in the psychedelic medicine space. It invests in drug discovery, clinics, addiction programs, retreats, AI, telemedicine, media, and training. Its global, platform-based approach helps to transform outcomes for patients with mental health, addiction, and chronic pain issues.
The $60m USD fund has backed 14 of the leading companies in the sector, spanning drug discovery, clinics, addiction, AI, and media, and has incubated 13 projects including The Psychedelic Medicine Association, the first psychedelic medicine SPAC, and Microdose, the profitable media company.
Contact:
Henri Sant-Cassia
Co-Founding Partner
Tel: +44 (0)7411 033 109
Email: henri@theconscious.fund
Website: www.theconscious.fund
